XML 23 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
MEDICARE PART D
 9 Months Ended
Sep. 30, 2017
Insurance [Abstract]  
MEDICARE PART D
MEDICARE PART D
We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with the Centers for Medicare and Medicaid Services, or CMS, as described further in Note 2 to the consolidated financial statements included in our 2016 Form 10-K. The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at September 30, 2017 and December 31, 2016. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers.
 
September 30, 2017
 
December 31, 2016
Risk
Corridor
Settlement
 
CMS
Subsidies/
Discounts
 
Risk
Corridor
Settlement
 
CMS
Subsidies/
Discounts
 
(in millions)
Other current assets
$
9

 
$
1,058

 
$
8

 
$
1,001

Trade accounts payable and accrued expenses
(118
)
 
(2,134
)
 
(158
)
 
(128
)
Net current (liability) asset
(109
)
 
(1,076
)
 
(150
)
 
873

Other long-term assets
3

 
—

 
—

 
—

Other long-term liabilities
(180
)
 
—

 
—

 
—

Net long-term liability
(177
)
 
—

 
—

 
—

Total net (liability) asset
$
(286
)
 
$
(1,076
)
 
$
(150
)
 
$
873